Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

Dean A. Fennell, Paul Baas, Paul Taylor, Anna K. Nowak, David Gilligan, Takashi Nakano, Jonathan A. Pachter, David T. Weaver, Arnaud Scherpereel, Nick Pavlakis, Jan P. van Meerbeeck, Susana Cedres, Luke Nolan, Hedy Kindler, Joachim G. J. V. Aerts

Research output: Contribution to journalArticlepeer-review

45 Citations (Web of Science)

Fingerprint

Dive into the research topics of 'Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study'. Together they form a unique fingerprint.

Medicine & Life Sciences